* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Quantumdotsbased fluoroimmunoassay for the rapid and sensitive
Survey
Document related concepts
Ebola virus disease wikipedia , lookup
Middle East respiratory syndrome wikipedia , lookup
Swine influenza wikipedia , lookup
Marburg virus disease wikipedia , lookup
West Nile fever wikipedia , lookup
Orthohantavirus wikipedia , lookup
Human cytomegalovirus wikipedia , lookup
Diagnosis of HIV/AIDS wikipedia , lookup
Surround optical-fiber immunoassay wikipedia , lookup
Henipavirus wikipedia , lookup
Antiviral drug wikipedia , lookup
Herpes simplex virus wikipedia , lookup
Hepatitis B wikipedia , lookup
Transcript
Research Article Received: 17 March 2009, Revised: 25 May 2009, Accepted: 20 June 2009, Published online in Wiley Online Library: 21 October 2009 (wileyonlinelibrary.com) DOI 10.1002/bio.1167 Quantum-dots-based fluoroimmunoassay for the rapid and sensitive detection of avian influenza virus subtype H5N1 Liping Chena,b, Zonghai Shengc, Anding Zhanga,b, Xuebo Guoa, Jiakui Lib, Heyou Hanc and Meilin Jina,b* ABSTRACT: The continuous spread of highly pathogenic avian influenza virus (AIV) subtype H5N1 is threatening the poultry industry and human health worldwide. Rapid and sensitive diagnostic methods are required for the H5N1 surveillance. In this study, the fluorescent (FL) probe of CdTe quantum dots (QDs) was designed using covalently linked rabbit anti-AIV H5N1 antibody. Based on these QD–antibody conjugates, a novel sandwich FL-linked immunosorbent assay (sFLISA) was developed for H5N1 viral antigen detection. The sFLISA allowed for H5N1 viral antigen determination in a linear range of 8.0 ¥ 10-3 to 5.1 ¥ 10-1 mg mL-1 with the limit of detection (LOD) of 1.5 ¥ 10-4 mg mL-1. In comparison with virus isolation for 103 clinic samples, the sensitivity and specificity of sFLISA were found to be 93.6 and 91.1% respectively. The sFLISA supplied a novel approach to rapid and sensitive detection of AIV subtype H5N1 and showed great potential for biological applications in immunoassays. Copyright © 2009 John Wiley & Sons, Ltd. Keywords: quantum dots; fluoroimmunoassay; avian influenza virus; subtype H5N1 Introduction Luminescence 2010; 25: 419–423 * Correspondence to: Meilin Jin, Unit of Animal Infectious Diseases, State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, People’s Republic of China. E-mail: [email protected] a Unit of Animal Infectious Diseases, State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan 430070, People’s Republic of China b College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, People’s Republic of China c College of Science, State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan 430070, People’s Republic of China Copyright © 2009 John Wiley & Sons, Ltd. 419 Avian influenza viruses (AIV) are agents for fatal poultry diseases. H5N1, a subtype of AIV, is of particular concern to people because of its ability to infect humans and the potential for person-toperson transmission. In 1997, 18 people were infected by H5N1 in Hong Kong and six died. (1) The recurrence of H5N1 in Southeast Asia in 2004, which resulted in the culling of millions of poultry birds and caused gigantic economic losses has attracted greater attention. (2) It was a shock that 394 people in 15 countries had been infected with H5N1 by 14 January 2009, among whom 248 had died. (3) H5N1 has not only endangered the poultry industry, but also poses a potential danger to global human health. Therefore, a rapid and sensitive detection assay for the early diagnosis of H5N1 is required to lower the chance of spread and prevent it from reaching epidemic levels. With the development of biotechnology, several analytical methods for the detection of H5N1 have been proposed, such as virus isolation (VI), standard reverse transcription-PCR (RT-PCR), real-time RT-PCR and enzyme-linked immunosorbent assay (ELISA). (4–7) Among then, VI is the gold standard method for the detection of H5N1. However, VI tends to be costly and slow. ELISA, a common method used for diagnosing AIV, has a comparatively low sensitivity and specificity. The emergence of quantum dots (QDs) has provided a novel tool for effective diagnostic methods in immunoassay. (8,9) Compared with conventional organic dyes and fluorescent protein, QDs have several excellent luminescent advantages, such as sizetunable light emission, superior signal brightness, resistance to photobleaching, and simultaneous excitation of multiple fluores- cent (FL) colors. (10,11) To date, immunoassays based on QDs have been tested for detection of antigens in multiplex assays. (12–15) However, until now there have been few reports on quantitative detection for virus based on QDs. In this strategy, QDs were conjugated with antibody, and used as an FL probe for antigen using sandwich immunoassys. Inspired by these, we attempted to developed an QDs-based-fluoroimmunoassay for rapid, sensitive and specific for the detection of H5N1. In the present work, a novel method for the determination of H5N1 virus was reported basd on QD fluoroimmunoassay. Under the optimal conditions, the limit of detection (LOD) of the proposed method reached 1.5 × 10−4 μg mL−1 of viral protein in virus preparations, which was lower than commercial enzyme-linked immunosorbent assay (ELISA). (4) Moreover, in comparison with virus isolation, this method has a high efficiency in clinical samples. L. Chen et al. Experimental Reagents and materials Thioglycolic acid (90%), Na2TeO3 (99%) and CdCl2.2.5H2O (99%) were purchased from Sinopharm Chemical Reagent Co. Ltd. NaBH4 (96%) was obtained from Shanghai Chemical Reagent Co. Ltd. N-hydroxysulfosuccinimide (NHS) and 1-ethyl-3-(3dimethylaminopropyl) carbodiimide (EDC) were purchased from Sigma-Aldrich. A commercial AIV Ag ELISA test kit was obtained from Wuhan Keqian Animal Biological Products Co. Ltd, Wuhan, China. Monoclonal antibody (MAb) against the hemagglutinin glycoprotein of H5N1 was made by ourselves. (16) AIV subtype H5N1 was kept in the Unit of Animal Infectious Diseases, State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University. The negative control specimen was obtained from a chicken in an AIV-free herd. Clinical samples were obtained from naturally infected chickens. All other chemicals were of analytical reagent grade and used without further purification. Ultrapure water obtained from Milli-Q purification system was used in all experiments. Instrumentation Ultraviolet–visible (UV–vis) absorption spectra were obtained on a Thermo Nicolet Corporation Model Evolution 300 UV–visible spectrometer. FL and resonance light scattering (RLS) spectra were acquired on a Perkin-Elmer Model LS-55 luminescence spectrometer. The TEM image of the QDs was performed on a transmission electron microscope (JEM-1010FEF, Japan). The concentration of protein was determined by a DU 800 UV–vis spectrophotometer (Beckman Coulter, USA). FL imaging (at ×20) was carried out using an IS70 inverted optical microscope (Olympus, Japan) equipped with a charge-coupled device camera (TOTA 500II, Japan) and a 100 W Hg excitation lamp. The FL intensity was detected by a Biotec Corporation Model Synergy HT multi-detection microplate reader. Preparation and purification of positive control antigen The positive control antigen was produced following a routine procedure using chicken embryos. The AIV subtype H5N1 strain A/chicken/HuBei/327/2004 (H5N1) stocks were propagated in 9-day-old embryonated specific-pathogen-free (SPF) chicken eggs. Allantoic fluid was collected at 24–96 h post-inoculation if HA titer was higher than 28. Collected allantoic fluid was purified by centrifugation at 8000 rpm, for 10 min and then ultracentrifuged at 27,000 rpm for 2 h. The viral pellet was resuspended in 10 mM phosphate-buffered saline (PBS; pH 7.4) containing 0.05% azide. The concentration of the viral protein was determined by measuring its optical density at 280 nm (OD280) and OD260 and calculating the content in accordance with the following formula: milligrams of protein per milliliter = (1.45 × OD280) − (0.74 × OD260). The purified virus stocks were aliquoted and stored at −70°C until used. Production and purified of polyclonal antibody angainst AIV subtype H5N1 420 Two New Zealand White male rabbits weighing 1 kg were chosen for preparing polyclonal antibody against AIV subtype H5N1. The rabbits were first immunized with 0.1 mg purified H5N1 virus in View this article online at wileyonlinelibrary.com an equal volume of Freund complete adjuvant, and immunized again at the third and fourth week respectively with 5 mg of the same antigen formulated in an equal volume of Freund incomplete adjuvant. Sera were collected 10 days after the last boost and the IgG was purified by protein A affinity column. The effect of purified IgG was evaluated by agarose-gel precipitation (AGP) and UV–vis spectrum analysis. Preparation of CdTe QDs and QDs-rabbit anti-AIV H5N1 antibody probe CdTe QDs were synthesized in a method suggested by Bao (17) with slight modifications. A 1.6 × 10−4 mol L−1 portion of CdCl2 was dissolved in 50 mL of deionized water in a 100 mL threeneck flask, and thioglycolic acid, trisodium citrate dehydrate, Na2TeO3 and NaBH4 were added under nitrogen atmosphere. The mol ratio of Cd2+, thioglycolic acid and Te2− was 3 : 9 : 1. When the color of the solution was changed to yellow, the solution was heated to the boil and kept under reflux for 6 h. The prepared CdTe QDs were characterized by UV–vis absorption and FL spectra. QDs-rabbit anti-AIV H5N1 antibody conjugates were prepared in the following way: the mixture containing 5 × 10−5 mol L−1 CdTe QDs, 0.05 mol L−1 EDC and 5.00 × 10−3 mol L−1 NHS in PBS buffer (0.05 mol L−1, pH 7.4) was prepared and reacted at room temperature for 30 min. The residual EDC and NHS were removed by washing three times in PBS, and centrifuged at 5000 rpm each for 5 min. After the last wash, the sediment was resuspended in PBS buffer. With gentle agitation, the rabbit anti-AIV H5N1 antibody in PBS (the molar ratio of antibody to QDs was 1.2) was added to the above suspension. The mixture was incubated at room temperature for 2 h and stored at 4°C overnight. Finally, the solution was centrifuged at 12,000 rpm for 30 min and the supernatant was stored at 4°C. Procedure for sFLISA The principle of sFLISA is shown in Fig. 1. In the study, first, antiAIV H5 monoclonal antibody (MAb) was bound to the polystyrene microplates, then the bound MAb specifically captured H5N1 viral antigen, and finally, the QDs-rabbit anti-AIV H5N1 antibody was selectively bound to the captured H5N1 viral antigen. MAb was diluted in sodium carbonate buffer (0.05 mol L−1, pH 9.6) at the optimal dilution and 100 μL was dispensed in each well of the 96-well polystyrene microplates which were later incubated overnight at 4°C. The microplates were washed three times with washing buffer (0.05% Tween-20 in PBS), and the excess binding sites were blocked by 5% skimmed milk (300 μL per well) at 37°C for 1 h. The solution was discarded, and the wells were washed with washing buffer, and then dried under vacuum and stored at 4°C. Samples were added to the wells of microplates which were incubated at 37°C for 30 min. After thorough washing, 100 μL of QDs-rabbit anti-AIV H5N1 antibody at the optimal dilution were added to each well of the microplates, which were then incubated at 37°C for another 30 min. After being washed five times, the microplates were dried. The FL signals of the microplates were detected by a multi-detection microplate reader with excitation wavelength at 420 nm and emission wavelength at 651 nm. The cutoff value of sFLISA was calculated from the mean FL signal of 60 tissue or swab samples known to be negative for AIV plus three times the standard deviation (SD). Copyright © 2009 John Wiley & Sons, Ltd. Luminescence 2010; 25: 419–423 Quantum-dots-based fluoroimmunoassay Figure 1. Schematic representation of the sandwich FL-linked immunosorbent assay (sFLISA) for the detection of AIV H5N1. (a) Immobilized MAb. (b) MAb-antigen conjugates. (c) MAb–antigen–QD–antibody conjugates. ELISA procedure ELISA for detection of H5N1 subtype antigen was performed according to the manufacturer’s instructions. Briefly, a series of dilutions of purified H5N1 virus were added to the anti-NP protein MAb-coated microplates and incubated at 37°C for 30 min. Then rabbit polyclonal IgG was added to each well, and next the peroxidase-conjugated goat anti-rabbit IgG conjugate. After thorough washing, tetramethylbenzidine substrate was added. The reaction was stopped by the addition of 0.25% hydrofluoric acid. The plates were read at 630 nm with an ELISA reader. VI procedure Figure 2. UV–vis absorbance (a) and FL (b) spectra of CdTe QDs. Isolation of influenza virus was performed by inoculating 9-dayembryonated chicken eggs with 0.2 mL tissue suspensions or swab suspensions via the allantoic cavity. The eggs were incubated for 4 days and candled daily for viability; embryos that died within 24 h of inoculation were discarded as nonspecific. Allantoic fluid collected 96 h later from dead and surviving embryos was tested for HA activity. Samples that did not show hemagglutination were reinoculated for a second passage. Results and discussion Characterization of CdTe QDs and QDs-rabbit anti-AIV H5N1 antibody probe Figure 3. TEM image of the CdTe QDs. Luminescence 2010; 25: 419–423 Figure 4. The resonance light scattering (RLS) spectra of QDs-rabbit anti-AIV H5N1 antibody probe (a) and QDs-antibody probe in the presence of H5N1 viral antigen (b). was immobilized as negative sample was almost all dark. (Fig. 5B). Both the RLS spectra and FL imagings indicated that the asprepared QDs were stably linked to the anti-HA polyclonal IgG, and formed QDs-rabbit anti-AIV H5N1 antibody conjugates. (20) Optimization of the sFLISA conditions For optimization of the dilution times of the antibody (anti-AIV H5N1 MAb and QDs-rabbit anti-AIV H5N1 antibody) used to Copyright © 2009 John Wiley & Sons, Ltd. View this article online at wileyonlinelibrary.com 421 Figure 2 shows UV–vis absorption and FL spectra of CdTe nanocrystals. It can be seen from curve (a) that the absorbance maximum wavelength was at 556 nm. The average size of the CdTe QDs was estimated to be 3.3 nm according to the method reported by Yu et al. (18) Furthermore, the FL spectra of CdTe QDs (curve b) exhibited a peak at 609 nm when excited at 390 nm. The sharp peaks of UV–vis and FL spectra indicated that the prepared CdTe QDs were nearly monodispersed and homogeneous. From the TEM image (see Fig. 3), it can be seen that the average size of CdTe nanoparticles is about 3 nm and their size distribution is relatively uniform. In this research, CdTe QDs were linked to rabbit anti-AIV H5N1 antibody using the coupling reagents EDC and NHS. The QDsrabbit anti-AIV H5N1 antibody probe were characterized by RLS spectra and FL imaging. As shown in Fig. 4, the RLS intensity of QDs-rabbit anti-AIV H5N1 antibody was remarkably increased in the presence of H5N1 viral antigen, which showed that larger particles were formed based on the immunoreaction between H5N1 viral antigen and the QDs-rabbit anti-AIV H5N1 antibody probe. (19) Further evidence for the effect of QDs-rabbit anti-AIV H5N1 antibody probe was also confirmed by FL imaging. Figure 5 showed two FL imagings from the sandwich conjugates bound on microplates after sFLISA. The QDs-rabbit anti-AIV H5N1 antibody probe recognized the H5N1 viral antigen specially and therefore led to extensive aggregation of the QDs and the microplate well which was immobilized H5N1 viral antigen showed red fluorescence (Fig. 5A). On the contrary, the well which L. Chen et al. Figure 5. FL imaging for the characterization of QDs-rabbit anti-AIV H5N1 antibody probe (examined by FL microscopy under violet excitation at 20× magification). (A) FL imaging in the presence of H5N1 viral antigen; (B) FL imaging in the presence of negative sample. capture and detect antigen, a checkerboard titration was performed. All the steps of sFLISA were performed as above. During optimization of those reagents, blocking buffer was used with 5% skimmed milk. A dilution of 1 : 3000 was selected for the monoclonal antibody, thereby ensuring a slight excess of capture antibody on the plates. A dilution of 1 : 1500 QD–rabbit anti-AIV H5N1 antibody was selected to maximize the detection of captured antigen. Under the optimal conditions, the cut-off level of the sFLISA (FL intensity = 20,000) was calculated as 3 standard deviations above the mean FL value (FL intensity = 16530 + 3790) obtained with 60 tissue and swab samples known to be negative for H5N1. Detection of H5N1 viral antigen The purified positive antigen (H5N1 virus) (102.4 μg mL−1) was serially diluted by PBS to different levels, and calibration curve was constructed using the optimized sFLISA conditions. As shown in Fig. 6, a good linear correlation between logarithm of FL intensity and the logarithm of concentration of H5N1 viral antigen was obtained in the range of 8.0 × 10−3 to 5.1 × 10−1 μg mL−1, with a regression equation, log(FL) = 4.69869 + 0.14647 logC (where C is the concentration of H5N1 virus), R2 = 0.992. As the the logarithm of concentration of H5N1 viral antigen increased, the logarithm of FL intensity increased between 8.0 × 10−3 and 5.1 × 10−1 μg mL−1. The results demonstrate the possibility of detecting H5N1 viral antigen at very low concentrations. The limit of detection The limit of detection was obtained by determination of the positive sample (H5N1 virus). According to the above procedure of sFLISA, H5N1 viral antigen was serially diluted in PBS and the limit of detection was obtained. Results showed that the limit of detection for sFLISA was approximately 1.5 × 10−4 μg mL−1 of viral protein, which was very low compared with other diagnostic methods. Comparison of sFLISA with ELISA and VI 422 ELISA and VI have been recognized as standard methods for diagnosing AIV. To evaluate the diagnostic performance of the sFLISA, it was necessary to compare sFLISA with the reference standards (VI and ELISA). View this article online at wileyonlinelibrary.com Figure 6. Linear relationship between logarithm of concentration of H5N1 viral antigen and logarithm of FL intensity. In present study, a commercially available ELISA was used as a control method to evaluate the sensitivity of sFLISA. The purified H5N1 virus was serially diluted in PBS and tested by sFLISA and ELISA simultaneously. For ELISA, data were analyzed according to the manufacturer’s instructions. Results showed that the limit of detection of ELISA was 5 × 10−3 μg mL−1, while that of sFLISA was 1.5 × 10−4 μg mL−1. Compared with ELISA, sFLISA showed higher sensitivity, which was extremely valuable for the early diagnosis of H5N1. In order to verify the application of the proposed method, 103 clinical chicken samples including hearts, livers, spleens, lungs, kidneys, muscles, tracheas, brains and cloaca swabs obtained from central China in 2005 were detected using the sFLISA and VI. The diagnostic performance of sFLISA was compared with that of VI, the current standard of AIV detection. As shown in Table 1, 44 samples were detected positive among all 103 samples in VI, but five more samples were detected positive with sFLISA. We named the 44 samples ture-positive (TP) and five as false-positive (FP). Similarly, 51 samples were detected negative among 103 samples in VI, but three more samples were detected negative in sFLISA. We called the 51 samples true-negative(TN), and three false-negative (FN). According to the following fomular: sensitivity = TP × 100/(TP + FN); specificity = TN × 100/(TN + FP); accuracy Copyright © 2009 John Wiley & Sons, Ltd. Luminescence 2010; 25: 419–423 Quantum-dots-based fluoroimmunoassay Table 1. Comparative results of the sFLISA and VI of 103 virus samples VI sFLISA Positive Negative Total Performance Positive Negative Total Sensitivity (%) Specificity (%) Accuracy (%) FP rate (%) FN rate (%) 44 3 47 5 51 56 49 54 103 93.6 91.1 92.2 8.9 6.4 Sensitivity = TP × 100/(TP + FN). Specificity = TN × 100/(TN + FP). Accuracy = (TP + TN) × 100/total. False-positive rate = FP × 100/ (FP + TN). False-negative rate = FN × 100/(TP + FN). = (TP + TN) × 100/total; false-positive rate = FP × 100/(FP + TN); false-negative rate = FN × 100/(TP + FN), we obtained the result that, compared with VI, sFLISA showed high sensitivity (93.6%), specificity (91.1%) and accuracy (92.2%), moderate false-positive rate (8.9%) and moderate false-negative rate (6.4%). Compared with VI, our sFLISA method provides remarkable advantages in terms of reliability and in practical uses, such as high sensitivity and specificity. Conclusions In conclusion, a novel method was developed for the detection of AIV subtype H5N1. The limit of detection was 1.5 × 10−4 μg mL−1, which was lower than ELISA. When it was applied to 103 clinic chicken samples (Table 1), the sFLISA showed high sensitivity (93.6%) and specificity (91.1%), and the agreement between sFLISA and VI was found to be 92.2%. The proposed method can be used to detect other animal disease biomarkers, and showed great potential for early diagnosis of major animal diseases. Acknowledgment This study was supported by China National Basic Research Program (China ‘973’ Program 2005CB523003), China National Scientific and Technical Supporting Programs (no. 2006BAD06A11 and no. 2006BAD06A15). References 1. Center for Disease Control and Prevention (CDC). Isolation of avian influenza A(H5N1) viruses from humans – Hong Kong, May–December 1997. MMWR Morb Mortal Wkly Rep 1997;46:1204–7. 2. Center for Disease Control and Prevention (CDC). Outbreaks of avian influenza A (H5N1) in Asia and interim recommendations for evaluation and reporting of suspected cases – United States, 2004. MMWR Morb Mortal Wkly Rep 2004;53:97–100. 3. World Health Organization (WHO). Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO. Available from: http://www.who.int/csr/disease/avian_influenza/country/ cases_table_2009_01_14/en/index.html. [Updated 14 January 2009]. 4. Zhang A, Jin M, Liu F, Guo X, Hu Q, Han L, Tan Y, Chen H. Development and evaluation of a DAS-ELISA for rapid detection of avian influenza viruses. Avian Dis 2006;50:325–30. 5. Lee MS, Chang PC, Shien JH, Cheng MC, Shieh HK. Identification and subtyping of avian influenza viruses by reverse-transcription PCR. J Virol Meth 2001;97:13–22. 6. Hoffmann B, Harder T, Starick E, Depner K, Werner O, Beer M. Rapid and highly sensitive pathotyping of avian influenza A H5N1 virus by using real-time reverse transcription-PCR. J Clin Microbiol 2007;45: 600–3. 7. He Q, Velumani S, Du Q, Lim CW, Ng FK, Donis R, Kwang J. Detection of H5 avian influenza viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal antibody. Clin Vaccine Immunol 2007;14:617–23. 8. Chan CWC, Nie S. Quantum Dot Bioconjugates for Ultrasensitive Nonisotopic Detection. Science 1998;281:2016–8. 9. Bruchez M Jr, Maronne M, Gin P, Weiss s, Alivisatos AP. Semiconductor Nanocrystals as Fluorescent Biological Labels. Science 1998;281: 2013–6. 10. Hua XF, Liu TC, Cao YC, Cao YC, Liu B, Wang HQ, Wang JH, Huang ZL, Zhao YD. Characterization of the coupling of quantum dots and immunoglobulin antibodies. Anal Bioanal Chem 2006;386:1665–71. 11. Wang LY, Wang L, Gao F, Yu ZY, Wu ZM. Application of functionalized CdS nanoparticles as fluorescence probe in the determination of nucleic acids. Analyst 2002;127:977–80. 12. Kerman K, Endo T, Tsukamoto M, Chikae M, Takamura Y, Tamiya E. Quantum dot-based immunosensor for the detection of prostatespecific antigen using fluorescence microscopy. Talanta 2007;71: 1494–9. 13. Yang DZ, Chen QF, Wang WX, Xu SK. Direct and indirect immunolabelling of HeLa cells with quantum dots. Luminescence 2008;23: 169–74. 14. Shen JZ, Xu F, Jiang HY, Wang ZH, Tong J, Guo PJ, Ding SY. Characterization and application of quantum dot nanocrystal–monoclonal antibody conjugates for the determination of sulfamethazine in milk by fluoroimmunoassay. Anal Bioanal Chem 2007;389:2243–50. 15. Ma Q, Wang XY, Li YB, Su XG, Jin QH. The use of CdTe quantum dot fluorescent microspheres in fluoro-immunoassays and a microfluidic chip system. Luminescence 2007;22:438–45. 16. Huang HL, Dan HB, Zhou YJ, Yu ZJ, Fan HY, Tong TZ, Jin ML, Chen HC. Different neutralization efficiency of neutralizing monoclonal antibodies against avian influenza H5N1 virus to virus strains from different hosts. Mol Immunol 2007;44:1052–5. 17. Bao HF, Wang EK, Dong SJ. One-pot synthesis of CdTe nanocrystals and shape control of luminescent CdTe-cystine nanocomposites. Small 2006;2:476–80. 18. Yu WW, Qu LH, Guo WZ, Peng XG. Experimental Determination of the Extinction Coefficient of CdTe, CdSe, and CdS Nanocrystals. Chem Mater 2003;15:2854–60. 19. Soman CP, Giorgio TD. Quantum dot self-assembly for protein detection with sub-picomolar sensitivity. Langmuir 2008;24:4399–404. 20. Wang XY, Ma Q, Li B, Li YB, Su XG. The preparation of CdTe nanoparticles and CdTe nanoparticle-labelled microspheres for biological applications. Luminescence 2007;22:1–8. 423 Luminescence 2010; 25: 419–423 Copyright © 2009 John Wiley & Sons, Ltd. View this article online at wileyonlinelibrary.com